Invesco IVZ
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$45.97M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 2.51% to 3.62% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| AQR Capital Management | Hedge Fund | 2026/Q4 | +5,846,387 | 4.1% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q4 | +2,915,470 | 1.1% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q4 | +1,617,557 | 1.2% |
| The Bank of Nova Scotia | Public Company | 2026/Q4 | +1,386,002 | 0.3% |
| UBS Asset Management | Mutual Fund | 2026/Q4 | +1,311,401 | 1.0% |
| Freestone Grove Partners LP | Hedge Fund | 2026/Q4 | +1,218,661 | 0.3% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q4 | +1,052,120 | 0.4% |
| JPMorgan Chase & Co. | Public Company | 2026/Q4 | +971,714 | 0.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q4 | +822,110 | 4.4% |
| Walleye Capital LLC | Hedge Fund | 2026/Q4 | +763,840 | 0.2% |
| Natixis S.A. | Private Company | 2026/Q4 | +759,341 | 0.2% |
| Morgan Stanley | Public Company | 2026/Q4 | +742,276 | 1.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q4 | +695,860 | 7.1% |
| BMO Asset Management | Mutual Fund | 2026/Q4 | +669,204 | 0.4% |
| Pacific Investment Management Company LLC | Mutual Fund | 2026/Q4 | +667,589 | 0.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 15 Oct 2026 | Shannon Johnston | Senior MD & Chief Information and Operations Officer | Derivative Exercise and Sale | -12,526 | $28.20 | 40,569 |
| 15 Oct 2026 | Shannon Johnston | Senior MD & Chief Information and Operations Officer | Derivative Exercise and Retained | +15,723 | – | 40,569 |
| 10 Sep 2026 | Phoebe Wood | Independent Non-Executive Director | Open Market Disposition | -3,000 | $32.44 | 107,111 |
| 8 Sep 2026 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Intent to Sell (Form 144) | -100,840 | $32.20 | – |
| 8 Sep 2026 | Stephanie Butcher | Senior MD & Co-Head of Investment | Open Market Disposition | -45,095 | $32.28 | 10,205 |
| 8 Sep 2026 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Open Market Disposition | -143,370 | $32.85 | 812,477 |
| 7 Sep 2026 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Intent to Sell (Form 144) | -42,530 | $32.85 | – |
| 3 Sep 2026 | Laura Dukes | Senior MD & CFO | Other Disposition | -7,600 | – | 251,583 |
| 3 Sep 2026 | Laura Dukes | Senior MD & CFO | Open Market Disposition | -31,075 | $33.16 | 251,583 |
| 30 Aug 2026 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Sale | -30,760 | $32.78 | 55,300 |
| 30 Aug 2026 | Stephanie Butcher | Senior MD & Co-Head of Investment | Derivative Exercise and Retained | +34,682 | – | 55,300 |
| 30 Aug 2026 | Douglas Sharp | Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK | Derivative Exercise and Sale | -22,213 | $32.78 | 88,387 |
| 30 Aug 2026 | Douglas Sharp | Senior MD, Head of the Americas and EMEA & Chair of the Board of Invesco UK | Derivative Exercise and Retained | +48,272 | – | 88,387 |
| 1 Jul 2026 | Jeffrey Kupor | Senior MD & General Counsel | Sale to Issuer | -26,002 | $27.01 | 125,818 |
| 1 Jul 2026 | Andrew Tak Lo | Senior MD & Head of Asia Pacific | Derivative Exercise and Retained | +116,754 | – | 955,847 |
| 1 Jul 2026 | Andrew Schlossberg | Chief Executive Officer | Sale to Issuer | -156,007 | $27.01 | 742,708 |
| 1 Jul 2026 | Laura Dukes | Senior MD & CFO | Sale to Issuer | -52,003 | $27.01 | 290,258 |
| 14 May 2026 | G. Wagoner | Chair of the Board | Other Acquisition | +8,112 | – | 122,870 |
| 14 May 2026 | Thomas Finke | Independent Non-Executive Director | Other Acquisition | +8,112 | – | 64,238 |
| 14 May 2026 | William Glavin | Independent Non-Executive Director | Other Acquisition | +8,112 | – | 81,084 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 15,909,802 | 3.6% | 2.8 |
| 15 Oct 2026 | 16,400,988 | 3.7% | 3.8 |
| 30 Sep 2026 | 16,111,028 | 3.6% | 3.1 |
| 15 Sep 2026 | 13,080,822 | 3.0% | 3.8 |
| 31 Aug 2026 | 12,375,805 | 2.8% | 3.6 |
| 14 Aug 2026 | 11,091,933 | 2.5% | 2.2 |
No comments yet — be the first to weigh in on IVZ.
Sign in to join the discussion.